Sign up to our newsletter Subscribe
We found for
Early Experience with Health Technology Assessment of Gene Therapies in the United States: Pricing and Paying for Cures

Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?
